Bryan McKiver

ORCID: 0000-0002-1447-5803
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pain Mechanisms and Treatments
  • Neuropeptides and Animal Physiology
  • HER2/EGFR in Cancer Research
  • Calpain Protease Function and Regulation
  • Cancer Treatment and Pharmacology
  • Nerve injury and regeneration
  • Chemotherapy-related skin toxicity
  • Nicotinic Acetylcholine Receptors Study
  • Ion channel regulation and function

Virginia Commonwealth University
2022-2023

Transmembrane Ca v 2.2 (N-type) voltage-gated calcium channels are genetically and pharmacologically validated, clinically relevant pain targets. Clinical block of (e.g., with Prialt/Ziconotide) or indirect modulation [e.g., gabapentinoids such as Gabapentin (GBP)] mitigates chronic but is encumbered by side effects abuse liability. The cytosolic auxiliary subunit collapsin response mediator protein 2 (CRMP2) targets to the sensory neuron membrane regulates their function via an...

10.1073/pnas.2305215120 article EN cc-by-nc-nd Proceedings of the National Academy of Sciences 2023-11-16

Background: Prior work suggests that patients with vitamin D insufficiency may have a higher risk of chemotherapy-induced peripheral neuropathy (CIPN) from paclitaxel. The objective this study was to validate as CIPN factor. Methods: We used data and samples the prospective phase III SWOG S0221 (ClinicalTrials.gov identifier: NCT00070564 ) trial compared paclitaxel-containing chemotherapy regimens for early-stage breast cancer. quantified pretreatment 25-hydroxy-vitamin in banked serum using...

10.6004/jnccn.2023.7062 article EN Journal of the National Comprehensive Cancer Network 2023-11-01
Coming Soon ...